STOCK TITAN

NewHold Investment IV (NHIV) 10-Q Filings

NHIV NASDAQ

Here are the 10-Q quarterly reports from NewHold Investment Corp IV (NHIV) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow NHIV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHIV filings page.

Rhea-AI Summary

NewHold Investment Corp IV (NHIV) reported net income of $1.414 million for the three months ended September 30, 2026, and $2.230 million for the nine months. It had no operating revenue; third-quarter results included $1.868 million of Trust Account investment income, $10,000 of operating-account interest income and $464,000 of general and administrative costs.

As of September 30, 2026, NHIV held $204.333 million in its Trust Account and $1.332 million in cash and cash equivalents, alongside $535,000 of current liabilities and $7.044 million of deferred underwriting payable, payable only upon completion of a business combination. The special purpose acquisition company has not selected a target. Its Combination Period extends to April 16, 2028, 24 months after the IPO closing, subject to an earlier board-approved or later shareholder-approved date; if no combination is completed by the end of the applicable period, it says it will redeem public shares from the Trust Account. NHIV also reported warrants to purchase 6,922,083 Class A ordinary shares, exercisable 30 days after a business combination at $11.50 per share.

Rhea-AI Summary

NewHold Investment Corp IV, a Cayman Islands SPAC, reported net income of $854,000 for the quarter and $816,000 for the six months ended June 30, 2026, driven mainly by $1,473,000 of interest income on funds in its trust and operating cash accounts, against general and administrative costs of $619,000 for the quarter.

Total assets were $204.3 million, including $202.7 million held in a Trust Account invested in U.S. government–backed money market funds, supporting 20,125,000 Class A ordinary shares subject to possible redemption at about $10.06 per share. Cash outside the trust was $1.33 million, with total current liabilities of $393,000 and deferred underwriting payable of $7.04 million, resulting in a shareholders’ deficit of $5.59 million. Management states available liquidity, including up to $250,000 per year of trust interest, is sufficient for at least one year while it seeks a business combination before the April 16, 2028 deadline.

Rhea-AI Summary

NewHold Investment Corp IV filed an amended quarterly report for the period ended March 31, 2026, to correct typographical errors, with no material changes to previously reported information. The company is a Cayman Islands-based blank check company formed to complete a Business Combination.

As of March 31, 2026, it had total assets of $281,000, mainly $277,000 of deferred offering costs, current liabilities of $341,000 (including an $86,000 related-party loan), and a shareholder’s deficit of $60,000. The company recorded a quarterly net loss of $38,000, entirely from general and administrative expenses, and had no revenues or cash.

Subsequently, on April 16, 2026, NewHold completed its SPAC IPO, selling 20,125,000 units at $10.00 each and a concurrent private placement of 641,250 units at $10.00, with $201,250,000 placed in a U.S. trust account to fund a future Business Combination. About $1,544,500 remained outside the trust to cover ongoing operating and transaction costs, while sponsor support includes a $350,000 promissory note and potential working capital loans.